CA 19-9 test cost in Rome, GA
In Rome, GA, 2 hospitals list a cash price for CA 19-9 blood test (tumor marker): from $68.50 to $894.24, with a median of $481.37. The lowest listed price is at Floyd Healthcare Management — $412.87 less than the median here. Across Georgia, the median is $86.40 at 36 hospitals.
Cash prices at 2 facilities for code 86301, as an outpatient — the setting a self-pay patient normally buys. Collected Sep 23, 2026; the hospital files themselves were last updated between Nov 19, 2025 and Apr 1, 2026.
Where each hospital's price falls
Each dot is one hospital's cash price on a scale from the lowest to the highest in Rome, GA.
Hospitals, cheapest first
| Hospital | Cash price | List price | Insurers pay | Off list | File date |
|---|---|---|---|---|---|
| Floyd Healthcare Management lowest Rome, GA HC IMMUNOASSAY TUMOR ANTIGEN CA 19-9 | $68.50 | $137.00 | $20.81–$116.45 | 50% | Nov 19, 2025 source file |
| AdventHealth Redmond Rome, GA · (706) 802-3012 HC CANCER ANTIGEN 19-9 | $894.24 | $894.24 | — | — | Apr 1, 2026 source file |
| AdventHealth Redmond Rome, GA · (706) 802-3012 HC CANCER ANTIGIEN 19-9 BODY FLUID - ARUP | $1,115.33 | $1,115.33 | — | — | Apr 1, 2026 source file |
Outpatient: lowest $68.50, median $481.37, highest $894.24 — a 13.1× difference within the same market.
As an inpatient, the same code is billed by 2 facilities here, median $481.37. Inpatient and outpatient prices are not comparable and are kept on separate pages: the inpatient charge covers admission, not the same purchase.
Cash or insurance?
At the one hospital here that publishes insurer rates for this code, the cash price is below the highest rate a health plan has negotiated. If you have insurance but have not met your deductible, you usually pay your plan's negotiated rate, which falls somewhere in the "Insurers pay" column. Paying cash can cost less, but a cash payment usually does not count toward your deductible. Ask the hospital for both numbers before you book.
What it is
CA 19-9 is a tumor marker used mainly to follow pancreatic and bile duct cancers during treatment.
What the price covers
The price usually covers running the test. The blood draw (36415) is often billed as a separate line.